{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:32:33Z","timestamp":1793496753101,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009367","name":"Mansoura University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009367","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Neurofibromatosis type 1 (NF1) is an autosomal dominant syndrome caused by mutations in the NF1 gene. Although cardiac abnormalities have been observed in NF1, they are frequently overlooked due to a lack of routine cardiac surveillance. Myocardial strain imaging offers a sensitive and non-invasive method for detecting early subclinical myocardial dysfunction. This study aims to detect cardiac abnormalities in children with NF1 using conventional echocardiography, Doppler tissue imaging (DTI), and myocardial strain analysis. A case\u2013control study was conducted on 38 asymptomatic children with clinically confirmed NF1 and 35 healthy, age- and sex-matched controls. All patients underwent ECG, conventional echocardiography, DTI, and two-dimensional speckle-tracking echocardiography. NF1 patients showed significantly decreased ejection fraction (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0009) and higher interventricular septal and posterior wall thickness during systole (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.0001). DTI revealed reduced mitral systolic (Sm) and early diastolic (Em) velocities, longer isovolumic contraction and relaxation periods, and increased LV Tei index values (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.0001), indicating combined systolic and diastolic dysfunction. Also, myocardial strain analysis in NF1 children revealed considerably lower peak systolic left ventricular global longitudinal strain (LVGLS) (\n                    <jats:italic>p<\/jats:italic>\n                    0.0014), as well as lower peak systolic septal and lateral wall strain values (\n                    <jats:italic>p<\/jats:italic>\n                    0.0046, 0.0027), respectively.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Conclusion<\/jats:italic>\n                    : Children with NF1 show early subclinical myocardial dysfunction, even when there is no hypertension or overt cardiac symptoms. These findings highlight the significance of frequent echocardiographic screening, including strain imaging, for the early diagnosis and longitudinal monitoring of heart function in NF1 children.\u00a0\n                    <jats:table-wrap>\n                      <jats:table>\n                        <jats:tbody>\n                          <jats:tr>\n                            <jats:td align=\"left\">\n                              <jats:bold>What is Known:<\/jats:bold>\n                              \u2022\n                              <jats:italic>Neurofibromatosis type 1 (NF1) is a multisystem syndrome that can involve the cardiovascular system.<\/jats:italic>\n                              \u2022\n                              <jats:italic>Previous studies showed hypertrophic cardiac changes in NF1 patients, but data in children, especially those without hypertension, are limited, as routine echocardiography is not involved in NF1 management.<\/jats:italic>\n                            <\/jats:td>\n                          <\/jats:tr>\n                          <jats:tr>\n                            <jats:td align=\"left\">\n                              <jats:bold>What is New:<\/jats:bold>\n                              \u2022\n                              <jats:italic>Our study revealed early subclinical myocardial dysfunction in NF1 children without the presence of hypertension or overt cardiac symptoms.<\/jats:italic>\n                              \u2022\n                              <jats:italic>This emphasizes the potential of myocardial strain imaging as a sensitive tool for early detection of myocardial dysfunction in NF1 children, thereby supporting the need for routine echocardiographic surveillance in these patients.<\/jats:italic>\n                            <\/jats:td>\n                          <\/jats:tr>\n                        <\/jats:tbody>\n                      <\/jats:table>\n                    <\/jats:table-wrap>\n                  <\/jats:p>","DOI":"10.1007\/s00431-025-06702-8","type":"journal-article","created":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T18:09:22Z","timestamp":1768500562000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Unraveling cardiac anomalies in pediatric neurofibromatosis type 1: insights and implications"],"prefix":"10.1007","volume":"185","author":[{"given":"Sohier","family":"Yahia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3632-6410","authenticated-orcid":false,"given":"Zahraa","family":"Abdelmoneim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Ghozzy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahya","family":"Wahba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hany M.","family":"Abo-Haded","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,15]]},"reference":[{"issue":"9","key":"6702_CR1","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1038\/gim.2017.215","volume":"20","author":"RA Kallionp\u00e4\u00e4","year":"2018","unstructured":"Kallionp\u00e4\u00e4 RA, Uusitalo E, Lepp\u00e4virta J, P\u00f6yh\u00f6nen M, Peltonen S, Peltonen J (2018) Prevalence of neurofibromatosis type 1 in the Finnish population. Genet Med 20(9):1082\u20131086","journal-title":"Genet Med"},{"key":"6702_CR2","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1146\/annurev-pathol-052016-100228","volume":"12","author":"CL Monroe","year":"2017","unstructured":"Monroe CL, Dahiya S, Gutmann DH (2017) Dissecting clinical heterogeneity in neurofibromatosis type 1. Annu Rev Pathol 12:53\u201374","journal-title":"Annu Rev Pathol"},{"issue":"1","key":"6702_CR3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/ng1059","volume":"33","author":"AD Gitler","year":"2003","unstructured":"Gitler AD, Zhu Y, Ismat FA, Lu MM, Yamauchi Y, Parada LF, Epstein JA (2003) Nf1 has an essential role in endothelial cells. Nat Genet 33(1):75\u201379","journal-title":"Nat Genet"},{"key":"6702_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/genes10090675","author":"V Pinna","year":"2019","unstructured":"Pinna V, Daniele P, Calcagni G, Mariniello L, Criscione R, Giardina C, Lepri FR, Hozhabri H, Alberico A, Cavone S et al (2019) Prevalence, type, and molecular spectrum of NF1 mutations in patients with neurofibromatosis type 1 and congenital heart disease. Genes. https:\/\/doi.org\/10.3390\/genes10090675","journal-title":"Genes"},{"key":"6702_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.704639","volume":"12","author":"W Wang","year":"2021","unstructured":"Wang W, Wei CJ, Cui XW, Li YH, Gu YH, Gu B, Li QF, Wang ZC (2021) Impacts of NF1 gene mutations and genetic modifiers in neurofibromatosis type 1. Front Neurol 12:704639","journal-title":"Front Neurol"},{"issue":"8","key":"6702_CR6","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1038\/s41436-021-01170-5","volume":"23","author":"E Legius","year":"2021","unstructured":"Legius E, Messiaen L, Wolkenstein P, Pancza P, Avery RA, Berman Y, Blakeley J, Babovic-Vuksanovic D, Cunha KS, Ferner R et al (2021) Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation. Genet Med 23(8):1506\u20131513","journal-title":"Genet Med"},{"issue":"10","key":"6702_CR7","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1007\/s00381-020-04708-1","volume":"36","author":"H Toledano-Alhadef","year":"2020","unstructured":"Toledano-Alhadef H, Mautner VF, Gugel I, Zipfel J, Haas-Lude K, Constantini S, Schuhmann MU (2020) Role, function and challenges of multidisciplinary centres for rare diseases exemplified for neurofibromatosis type 1 syndrome. Childs Nerv Syst 36(10):2279\u20132284","journal-title":"Childs Nerv Syst"},{"issue":"8","key":"6702_CR8","first-page":"714","volume":"43","author":"F \u0130ncecik","year":"2015","unstructured":"\u0130ncecik F, Herg\u00fcner \u00d6M, Al\u0131n\u00e7 Erdem S, Altunba\u015fak \u015e (2015) Neurofibromatosis type 1 and cardiac manifestations. Turk Kardiyol Dern Ars 43(8):714\u2013716","journal-title":"Turk Kardiyol Dern Ars"},{"issue":"12","key":"6702_CR9","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1002\/ajmg.a.40632","volume":"176","author":"KA Rauen","year":"2018","unstructured":"Rauen KA, Schoyer L, Schill L, Stronach B, Albeck J, Andresen BS, Cav\u00e9 H, Ellis M, Fruchtman SM, Gelb BD et al (2018) Proceedings of the fifth international RASopathies symposium: when development and cancer intersect. Am J Med Genet A 176(12):2924\u20132929","journal-title":"Am J Med Genet A"},{"issue":"3","key":"6702_CR10","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/ajmg.a.32140","volume":"146a","author":"EA Croonen","year":"2008","unstructured":"Croonen EA, van der Burgt I, Kapusta L, Draaisma JM (2008) Electrocardiography in Noonan syndrome PTPN11 gene mutation - phenotype characterization. Am J Med Genet A 146a(3):350\u2013353","journal-title":"Am J Med Genet A"},{"issue":"4","key":"6702_CR11","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1111\/cge.12072","volume":"84","author":"R Nguyen","year":"2013","unstructured":"Nguyen R, Mir TS, Kluwe L, Jett K, Kentsch M, Mueller G, Kehrer-Sawatzki H, Friedman JM, Mautner VF (2013) Cardiac characterization of 16 patients with large NF1 gene deletions. Clin Genet 84(4):344\u2013349","journal-title":"Clin Genet"},{"issue":"3","key":"6702_CR12","doi-asserted-by":"publisher","DOI":"10.1093\/omcr\/omz021","volume":"2019","author":"M Ibarrola","year":"2019","unstructured":"Ibarrola M, P\u00e9rez-Riera AR, Gonz\u00e1lez MD (2019) Left ventricular noncompaction and orthodromic atrioventricular tachycardia observed in a patient with neurofibromatosis type 1. Oxf Med Case Reports 2019(3):omz021","journal-title":"Oxf Med Case Reports"},{"issue":"9","key":"6702_CR13","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.echo.2012.06.008","volume":"25","author":"MK Friedberg","year":"2012","unstructured":"Friedberg MK, Mertens L (2012) Deformation imaging in selected congenital heart disease: is it evolving to clinical use? J Am Soc Echocardiogr 25(9):919\u2013931","journal-title":"J Am Soc Echocardiogr"},{"key":"6702_CR14","doi-asserted-by":"crossref","unstructured":"Merkx R, Leerink JM, Feijen E, de Baat EC, Bellersen L, Bresters D, van Dalen EC, van Dulmen-den Broeder E, van der Heiden-van der Loo M, van den Heuvel-Eibrink MM, et al. (2023) Extensive cardiac function analyses using contemporary echocardiography in childhood cancer survivors: a DCCSS LATER study. JACC CardioOncol 5(4): 472\u2013485","DOI":"10.1016\/j.jaccao.2023.06.003"},{"key":"6702_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10010154","author":"M Laufer-Perl","year":"2021","unstructured":"Laufer-Perl M, Gilon D, Kapusta L, Iakobishvili Z (2021) The role of speckle strain echocardiography in the diagnosis of early subclinical cardiac injury in cancer patients-is there more than just left ventricle global longitudinal strain? J Clin Med. https:\/\/doi.org\/10.3390\/jcm10010154","journal-title":"J Clin Med"},{"issue":"1","key":"6702_CR16","doi-asserted-by":"publisher","first-page":"12070","DOI":"10.1038\/s41598-020-68908-0","volume":"10","author":"A Cutruzzol\u00e0","year":"2020","unstructured":"Cutruzzol\u00e0 A, Irace C, Frazzetto M, Sabatino J, Gullace R, De Rosa S, Spaccarotella C, Concolino D, Indolfi C, Gnasso A (2020) Functional and morphological cardiovascular alterations associated with neurofibromatosis 1. Sci Rep 10(1):12070","journal-title":"Sci Rep"},{"issue":"7","key":"6702_CR17","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1007\/s10554-024-03125-8","volume":"40","author":"L Kapusta","year":"2024","unstructured":"Kapusta L, Beer G, Rothschild E, Baruch G, Barkay G, Marom D, Grinshpun-Cohen Y, Raskind C, Constantini S, Toledano-Alhadef H (2024) Cardiac screening in pediatric patients with neurofibromatosis type 1: similarities with Noonan syndrome? Int J Cardiovasc Imaging 40(7):1475\u20131482","journal-title":"Int J Cardiovasc Imaging"},{"issue":"6","key":"6702_CR18","first-page":"357","volume":"26","author":"C Tei","year":"1995","unstructured":"Tei C, Ling LH, Hodge DO, Bailey KR, Oh JK, Rodeheffer RJ, Tajik AJ, Seward JB (1995) New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function\u2013a study in normals and dilated cardiomyopathy. J Cardiol 26(6):357\u2013366","journal-title":"J Cardiol"},{"issue":"10","key":"6702_CR19","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/S0002-9149(01)02062-8","volume":"88","author":"MA Tedesco","year":"2001","unstructured":"Tedesco MA, Di Salvo G, Natale F, Caputo S, Calabrese E, Grassia C, Ratti G, Iarussi D, Iacono A, Lama G (2001) Cardiac abnormalities detected by doppler imaging in patients with neurofibromatosis type 1. Am J Cardiol 88(10):1198\u20131200","journal-title":"Am J Cardiol"},{"key":"6702_CR20","doi-asserted-by":"crossref","unstructured":"Omar AMS, Sengupta PP (2018) Myocardial deformation imaging. Echocardiography: Springer p. 129\u2013157.","DOI":"10.1007\/978-3-319-71617-6_7"},{"issue":"11","key":"6702_CR21","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1080\/14779072.2016.1226129","volume":"14","author":"L Venneri","year":"2016","unstructured":"Venneri L, Khattar RS (2016) Cancer and myocardial dysfunction: is there a link? Expert Rev Cardiovasc Ther 14(11):1207\u20131209","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"21","key":"6702_CR22","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1136\/heartjnl-2014-305538","volume":"100","author":"K Kalam","year":"2014","unstructured":"Kalam K, Otahal P, Marwick TH (2014) Prognostic implications of global LV dysfunction: a systematic review and meta-analysis of global longitudinal strain and ejection fraction. Heart 100(21):1673\u20131680","journal-title":"Heart"},{"key":"6702_CR23","doi-asserted-by":"crossref","unstructured":"Luis SA, Chan J, Pellikka PA (2019) Echocardiographic assessment of left ventricular systolic function: an overview of contemporary techniques, including speckle-tracking echocardiography. Mayo Clin Proc 94(1): 125\u2013138","DOI":"10.1016\/j.mayocp.2018.07.017"},{"issue":"9","key":"6702_CR24","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.echo.2014.07.012","volume":"27","author":"JC Plana","year":"2014","unstructured":"Plana JC, Galderisi M, Barac A, Ewer MS, Ky B, Scherrer-Crosbie M, Ganame J, Sebag IA, Agler DA, Badano LP et al (2014) Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 27(9):911\u2013939","journal-title":"J Am Soc Echocardiogr"},{"issue":"1","key":"6702_CR25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1006\/nbdi.1995.0002","volume":"2","author":"KK Norton","year":"1995","unstructured":"Norton KK, Xu J, Gutmann DH (1995) Expression of the neurofibromatosis I gene product, neurofibromin, in blood vessel endothelial cells and smooth muscle. Neurobiol Dis 2(1):13\u201321","journal-title":"Neurobiol Dis"},{"key":"6702_CR26","doi-asserted-by":"crossref","unstructured":"Kurien A, John PR, Milford DV (1997) Hypertension secondary to progressive vascular neurofibromatosis. Arch Dis Child 76(5): 454-455.","DOI":"10.1136\/adc.76.5.454"},{"key":"6702_CR27","doi-asserted-by":"crossref","unstructured":"Caiffa T, Tessitore A, Magnolato A, Petz M, Bobbo M, Chicco D, D'Agata Mottolese B, Porcari A, Barbi E, Sinagra G, et al. (2023) Characterization of Cardiac Function by Echocardiographic Global Longitudinal Strain in a Cohort of Children with Neurofibromatosis Type 1 Treated with Selumetinib. Paediatr Drugs 25(2):217-224.","DOI":"10.1007\/s40272-022-00551-w"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-025-06702-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-025-06702-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-025-06702-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T15:21:14Z","timestamp":1772551274000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-025-06702-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,15]]},"references-count":27,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["6702"],"URL":"https:\/\/doi.org\/10.1007\/s00431-025-06702-8","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,15]]},"assertion":[{"value":"11 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted by the principles outlined in the Declaration of Helsinki. The study protocol was approved by the Ethics Committee of the Mansoura Faculty of Medicine-Institutional Research Board (Code number: R.24.11.2870).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all patient caregivers before inclusion in the study and after assuring confidentiality.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"N\/A.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"79"}}